Related Experiment Videos
4-Ipomeanol-induced effects on Sendai viral pneumonia in mice
Abstract:
The effects of the pulmonary toxicant, 4-ipomeanol (4-IP), on Sendai viral pneumonia was examined in young adult female C57BL/6J mice. The histologic severity of the pneumonia was closely correlated with increasing doses of the compound. The more severe pneumonia observed in the 4-IP-treated animals was associated with higher pulmonary viral titers and a more diffuse distribution of viral antigen in bronchioles and alveolar parenchyma. There was no difference in the systemic humoral immune response against Sendai virus or pulmonary interferon production in animals that had received 4-IP or vehicle pretreatment. Classification of the antigen-positive cell types in the alveolar parenchyma resulted in a marked relative increase in the numbers of antigen-positive macrophages, as compared with other antigen-positive cell types.
Insights
Pulmonary toxicant 4-ipomeanol (4-IP) worsens Sendai viral pneumonia in mice by increasing viral load and antigen distribution. This lung injury did not affect systemic immunity or interferon levels.
Area of Science:
- Pulmonary toxicology
- Virology
- Immunology
Background:
- Sendai virus is a common respiratory pathogen.
- 4-ipomeanol (4-IP) is a known pulmonary toxicant.
- Understanding toxicant-virus interactions is crucial for respiratory health.
Purpose of the Study:
- To investigate the impact of 4-ipomeanol on Sendai viral pneumonia.
- To assess the role of 4-IP in viral replication and host response.
Main Methods:
- C57BL/6J mice were exposed to varying doses of 4-ipomeanol.
- Mice were infected with Sendai virus.
- Histologic severity, viral titers, and immune responses were analyzed.
Main Results:
- Histologic pneumonia severity correlated with 4-IP dose.
- 4-IP treatment led to higher pulmonary viral titers and antigen spread.
- No significant differences in systemic antibody or interferon responses were observed.
- Antigen-positive macrophages increased in 4-IP-treated lungs.
Conclusions:
- 4-ipomeanol exacerbates Sendai viral pneumonia.
- The exacerbation is linked to increased viral load and altered immune cell response in the lungs.
- Pulmonary toxicity can significantly impact viral pneumonia pathogenesis.